Venrock Healthcare Capital Partners III, L.P. - Insider Trading & Ownership

Location
530 Fifth Avenue, 22 Nd Floor, New York, NY
Summary
The estimated value of insider holdings of Venrock Healthcare Capital Partners III, L.P. is at least $97.4M dollars as of April 11, 2025. Venrock Healthcare Capital Partners III, L.P. is the 10%+ Owner of KalVista Pharmaceuticals, Inc. and owns shares of KalVista Pharmaceuticals, Inc. (KALV) stock worth about $50M. Venrock Healthcare Capital Partners III, L.P. is the 10%+ Owner of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $47.5M.
Signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
All Insider Reports
All Insider Reports

Notify me when Venrock Healthcare Capital Partners III, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Venrock Healthcare Capital Partners III, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KALV KalVista Pharmaceuticals, Inc. 10%+ Owner $50M +$3.32M +7.12% Apr 9, 2025
ORKA Oruka Therapeutics, Inc. 10%+ Owner $47.5M +$1.41M +3.06% Feb 10, 2025

Insider Transactions Reported by Venrock Healthcare Capital Partners III, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.